Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Jurnal Riset Farmasi Jurnal Farmasi Indonesia
Badriyah, Rani Nur
Unknown Affiliation
Chemistry Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis Persepsi Kemampuan Mahasiswa dengan Asesmen Mandiri dalam Pembelajaran Praktik Kerja Profesi Apoteker (PKPA) di Instalasi Farmasi RSUD Dr. Saiful Anwar Badriyah, Rani Nur; Puspitasari , Vicky; Widya, Reta Anggraeni
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol 17 No 1 (2025): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfionline.v17i1.270

Abstract

Pharmacist Professional Work Practice (PKPA) provides a learning process for students to gain basic skills in pharmaceutical services. Student perceptions are important to be involved in the development of the PKPA curriculum at the Dr. Saiful Anwar Hospital Pharmacy Department. The purpose of the study was to determine the basic abilities of students in pharmaceutical services during the PKPA process. Perceptions were assessed by self-assessment in the form of a questionnaire containing 7 questions, namely the ability to reconcile drugs, need for drug, selection of drug, analyze Drug Related Problems (DRP), provision of drug product, medicines information and patient education, and Monitoring Drug Therapy (PTO) before starting PKPA (Pre) and after PKPA ended (Post) in 76 students. Students' perceptions of self-assessment provide results in the category of exceeding expectations (index 86.2%), but several abilities are the top priority for improvement, namely need for drug, medicines information and patient education. Based on this, it can be concluded that students have the perception of having overall pharmaceutical service skills but further assessment needs to be done to test the suitability of perceptions with the abilities possessed by students.
Studi Penggunaan Antihipertensi Golongan Calcium Channel Blocker pada Pasien Stroke Iskemik Amanda, Anita Tria; Syifa, Nailis; Hasmono, Didik; Badriyah, Rani Nur
Jurnal Riset Farmasi Volume 5, No. 2, Desember 2025, Jurnal Riset Farmasi (JRF)
Publisher : UPT Publikasi Ilmiah Unisba

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/jrf.v5i2.8108

Abstract

Abstract. Ischemic stroke is a leading cause of disability and death in Indonesia, with hypertension as the biggest risk factor. Blood pressure control is key to therapy, one of which is through the use of Calcium Channel Blockers (CCBs) that work by arterial vasodilation. This study aims to determine the pattern of CCB use in ischemic stroke patients at Dr. Saiful Anwar Regional Hospital, including drug type, dose, route, frequency, duration of therapy (>3 days), and length of hospitalization (>7 days). The study used a retrospective descriptive design based on medical records data from 2024. The results showed Amlodipine (1 × 10 mg) po as the most common single therapy (71 patients; 40%). Combinations of two drugs, such as Amlodipine and Valsartan, were used in 23 patients (15%), while combinations of three and four drugs were used in 6 (3%) and 2 patients (1%), respectively. In addition, there were 73 cases (41%) of regimen changes during treatment. These findings emphasize the importance of adjusting antihypertensive therapy based on clinical conditions and evaluating the rationality of drug use to improve therapeutic outcomes. Abstrak. Stroke iskemik merupakan penyebab utama kecacatan dan kematian di Indonesia, dengan hipertensi sebagai faktor risiko terbesar. Pengendalian tekanan darah menjadi kunci terapi, salah satunya melalui penggunaan Calcium Channel Blocker (CCB) yang bekerja dengan vasodilatasi arteri. Penelitian ini bertujuan mengetahui pola penggunaan CCB pada pasien stroke iskemik di RSUD Dr. Saiful Anwar, meliputi jenis obat, dosis, rute, frekuensi, durasi terapi (>3 hari), serta lama rawat inap (>7 hari). Penelitian menggunakan desain deskriptif retrospektif berdasarkan data rekam medis tahun 2024. Hasil menunjukkan Amlodipin (1 × 10 mg) po sebagai terapi tunggal terbanyak (71 pasien; 40%). Kombinasi dua obat, seperti Amlodipin dan Valsartan, digunakan pada 23 pasien (15%), sedangkan kombinasi tiga dan empat obat pada 6 (3%) dan 2 pasien (1%). Selain itu, terdapat 73 kasus (41%) perubahan regimen selama perawatan. Temuan ini menegaskan pentingnya penyesuaian terapi antihipertensi berdasarkan kondisi klinis serta evaluasi rasionalitas penggunaan obat untuk meningkatkan luaran terapi.
Co-Authors Amanda, Anita Tria Didik Hasmono Nailis Syifa Puspitasari , Vicky Widya, Reta Anggraeni